XTX Topco Ltd Has $1.13 Million Stock Position in UiPath Inc. (NYSE:PATH)

XTX Topco Ltd lifted its holdings in shares of UiPath Inc. (NYSE:PATH) by 402.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 89,381 shares of the healthcare company’s stock after purchasing an additional 71,575 shares during the period. XTX Topco Ltd’s holdings in UiPath were worth $1,133,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of PATH. ORG Partners LLC grew its position in shares of UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after buying an additional 1,112 shares during the last quarter. Hantz Financial Services Inc. bought a new stake in UiPath in the second quarter valued at approximately $28,000. Redwood Wealth Management Group LLC bought a new stake in UiPath in the second quarter valued at approximately $43,000. Lindbrook Capital LLC increased its position in UiPath by 46.0% during the 1st quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock valued at $46,000 after purchasing an additional 639 shares during the period. Finally, GAMMA Investing LLC raised its holdings in UiPath by 40.2% during the 1st quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock worth $50,000 after purchasing an additional 632 shares during the last quarter. Institutional investors own 62.50% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. Scotiabank decreased their price objective on shares of UiPath from $30.00 to $25.00 and set a “sector perform” rating for the company in a research report on Wednesday, May 29th. Wells Fargo & Company lifted their price objective on UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research report on Friday, September 6th. Bank of America upped their target price on UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Truist Financial reiterated a “hold” rating and issued a $14.00 target price (down from $32.00) on shares of UiPath in a report on Thursday, May 30th. Finally, William Blair downgraded shares of UiPath from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 30th. Sixteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $17.71.

UiPath Trading Up 0.3 %

Shares of NYSE:PATH opened at $12.49 on Friday. The stock has a market cap of $7.15 billion, a PE ratio of -78.06 and a beta of 0.87. The stock’s fifty day simple moving average is $12.13 and its two-hundred day simple moving average is $16.01. UiPath Inc. has a 1-year low of $10.37 and a 1-year high of $27.87.

UiPath (NYSE:PATH) last released its quarterly earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business had revenue of $316.00 million for the quarter, compared to analysts’ expectations of $303.69 million. During the same period in the previous year, the company earned ($0.09) earnings per share. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. On average, sell-side analysts forecast that UiPath Inc. will post -0.23 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Ashim Gupta sold 47,671 shares of the firm’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $12.07, for a total transaction of $575,388.97. Following the completion of the sale, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at approximately $10,258,498.19. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 22.37% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.